OMIA:001482-9940 : Neuronal ceroid lipofuscinosis, 5 in Ovis aries (sheep)

In other species: dog , taurine cattle

Categories: Lysosomal storage disease , Nervous system phene

Links to possible relevant human trait(s) and/or gene(s) in OMIM: 256731 (trait) , 608102 (gene)

Links to relevant human diseases in MONDO:

Mendelian trait/disorder: yes

Mode of inheritance: Autosomal recessive

Considered a defect: yes

Key variant known: yes

Year key variant first reported: 2008

Cross-species summary: One of several variants of neuronal ceroid lipofuscinosis (NCL) or Batten disease: CLN5; NCL5

History: This disorder in sheep was first reported by Jolly et al. (2002) in Borderdale breed in New Zealand.

Molecular basis: Using the comparative positional candidate gene approach, Frugier et al. (2008) discovered the causative mutation in the Borderdale breed to be "a substitution at a consensus splice site (c.571+1G>A) [of the CLN5 gene], leading to the excision of exon 3 and a truncated putative protein."

Breed: Borderdale, New Zealand (Sheep) (VBO_0016308).
Breeds in which the phene has been documented. (If a likely causal variant has been documented for the phene, see the variant table breeds in which the variant has been reported).

Associated gene:

Symbol Description Species Chr Location OMIA gene details page Other Links
CLN5 ceroid-lipofuscinosis, neuronal 5 Ovis aries 10 NC_056063.1 (52713507..52724305) CLN5 Homologene, Ensembl , NCBI gene


By default, variants are sorted chronologically by year of publication, to provide a historical perspective. Readers can re-sort on any column by clicking on the column header. Click it again to sort in a descending order. To create a multiple-field sort, hold down Shift while clicking on the second, third etc relevant column headers.

WARNING! Inclusion of a variant in this table does not automatically mean that it should be used for DNA testing. Anyone contemplating the use of any of these variants for DNA testing should examine critically the relevant evidence (especially in breeds other than the breed in which the variant was first described). If it is decided to proceed, the location and orientation of the variant sequence should be checked very carefully.

Since October 2021, OMIA includes a semiautomated lift-over pipeline to facilitate updates of genomic positions to a recent reference genome position. These changes to genomic positions are not always reflected in the ‘acknowledgements’ or ‘verbal description’ fields in this table.

OMIA Variant ID Breed(s) Variant Phenotype Gene Allele Type of Variant Source of Genetic Variant Reference Sequence Chr. g. or m. c. or n. p. Verbal Description EVA ID Year Published PubMed ID(s) Acknowledgements
389 Borderdale, New Zealand (Sheep) Neuronal ceroid lipofuscinosis, 5 CLN5 splicing Naturally occurring variant Oar_rambouillet_v1.0 10 g.56313269G>A c.571+1G>A rs422165326 2008 17988881 The genomic location on Oar_rambouillet_v1.0 was determined by Katie Eager, EMAI, NSW Department of Primary Industries.

Cite this entry

Nicholas, F. W., Tammen, I., & Sydney Informatics Hub. (2013). OMIA:001482-9940: Online Mendelian Inheritance in Animals (OMIA) [dataset].


Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.

2023 Mitchell, N.L., Murray, S.J., Wellby, M.P., Barrell, G.K., Russell, K.N., Deane, A.R., Wynyard, J.R., Palmer, M.J., Pulickan, A., Prendergast, P.M., Casy, W., Gray, S.J., Palmer, D.N. :
Long-term safety and dose escalation of intracerebroventricular CLN5 gene therapy in sheep supports clinical translation for CLN5 Batten disease. Front Genet 14:1212228, 2023. Pubmed reference: 37614821. DOI: 10.3389/fgene.2023.1212228.
Mitchell, N.L., Russell, K.N., Barrell, G.K., Tammen, I., Palmer, D.N. :
Characterization of neuropathology in ovine CLN5 and CLN6 neuronal ceroid lipofuscinoses (Batten disease). Dev Neurobiol 83:127-142, 2023. Pubmed reference: 37246363. DOI: 10.1002/dneu.22918.
Murray, S.J., Wellby, M.P., Barrell, G.K., Russell, K.N., Deane, A.R., Wynyard, J.R., Gray, S.J., Palmer, D.N., Mitchell, N.L. :
Efficacy of dual intracerebroventricular and intravitreal CLN5 gene therapy in sheep prompts the first clinical trial to treat CLN5 Batten disease. Front Pharmacol 14:1212235, 2023. Pubmed reference: 37942487. DOI: 10.3389/fphar.2023.1212235.
Murray, S.J., Almuqbel, M.M., Felton, S.A., Palmer, N.J., Myall, D.J., Shoorangiz, R., Ella, A., Keller, M., Palmer, D.N., Melzer, T.R., Mitchell, N.L. :
Progressive MRI brain volume changes in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinosis. Brain Commun 5:fcac339, 2023. Pubmed reference: 36632184. DOI: 10.1093/braincomms/fcac339.
2022 Banstola, A., Reynolds, J.N.J. :
The sheep as a large animal model for the investigation and treatment of human disorders. Biology (Basel) 11:1251, 2022. Pubmed reference: 36138730. DOI: 10.3390/biology11091251.
Eaton, S.L., Murdoch, F., Rzechorzek, N.M., Thompson, G., Hartley, C., Blacklock, B.T., Proudfoot, C., Lillico, S.G., Tennant, P., Ritchie, A., Nixon, J., Brennan, P.M., Guido, S., Mitchell, N.L., Palmer, D.N., Whitelaw, C.B.A., Cooper, J.D., Wishart, T.M. :
Modelling neurological diseases in large animals: Criteria for model selection and clinical assessment. Cells 11:2641, 2022. Pubmed reference: 36078049. DOI: 10.3390/cells11172641.
Murray, S.J., Mitchell, N.L. :
Natural history of retinal degeneration in ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses. Sci Rep 12:3670, 2022. Pubmed reference: 35256654. DOI: 10.1038/s41598-022-07612-7.
Murray, S.J., Mitchell, N.L. :
The translational benefits of sheep as large animal models of human neurological disorders. Front Vet Sci 9:831838, 2022. Pubmed reference: 35242840. DOI: 10.3389/fvets.2022.831838.
2021 Basak, I., Wicky, H.E., McDonald, K.O., Xu, J.B., Palmer, J.E., Best, H.L., Lefrancois, S., Lee, S.Y., Schoderboeck, L., Hughes, S.M. :
A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis. Cell Mol Life Sci 78:4735-63, 2021. Pubmed reference: 33792748. DOI: 10.1007/s00018-021-03813-x.
Jolly, R.D., Dittmer, K.E., Jones, B.R., Worth, A.J., Thompson, K.G., Johnstone, A.C., Palmer, D.N., Van de Water, N.S., Hemsley, K.M., Garrick, D.J., Winchester, B.G., Walkley, S.U. :
Animal medical genetics: a historical perspective on more than 50 years of research into genetic disorders of animals at Massey University. N Z Vet J 69:255-266, 2021. Pubmed reference: 33969809. DOI: 10.1080/00480169.2021.1928564.
Murray, S.J., Russell, K.N., Melzer, T.R., Gray, S.J., Heap, S.J., Palmer, D.N., Mitchell, N.L. :
Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease. Exp Eye Res 207:108600, 2021. Pubmed reference: 33930398. DOI: 10.1016/j.exer.2021.108600.
Russell, K.N., Mitchell, N.L., Wellby, M.P., Barrell, G.K., Palmer, D.N. :
Electroretinography data from ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses. Data Brief 37:107188, 2021. Pubmed reference: 34141843. DOI: 10.1016/j.dib.2021.107188.
2018 Mitchell, N.L., Russell, K.N., Wellby, M.P., Wicky, H.E., Schoderboeck, L., Barrell, G.K., Melzer, T.R., Gray, S.J., Hughes, S.M., Palmer, D.N. :
Longitudinal in vivo monitoring of the CNS demonstrates the efficacy of gene therapy in a sheep model of CLN5 Batten disease. Mol Ther 26:2366-2378, 2018. Pubmed reference: 30078766. DOI: 10.1016/j.ymthe.2018.07.015.
Russell, K.N., Mitchell, N.L., Anderson, N.G., Bunt, C.R., Wellby, M.P., Melzer, T.R., Barrell, G.K., Palmer, D.N. :
Computed tomography provides enhanced techniques for longitudinal monitoring of progressive intracranial volume loss associated with regional neurodegeneration in ovine neuronal ceroid lipofuscinoses. Brain Behav 8:e01096, 2018. Pubmed reference: 30136763. DOI: 10.1002/brb3.1096.
2015 Amorim, I.S., Mitchell, N.L., Palmer, D.N., Sawiak, S.J., Mason, R., Wishart, T.M., Gillingwater, T.H. :
Molecular neuropathology of the synapse in sheep with CLN5 Batten disease. Brain Behav 5:e00401, 2015. Pubmed reference: 26664787. DOI: 10.1002/brb3.401.
Palmer, D.N., Neverman, N.J., Chen, J.Z., Chang, C.T., Houweling, P.J., Barry, L.A., Tammen, I., Hughes, S.M., Mitchell, N.L. :
Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network. Biochim Biophys Acta 1852:2279-86, 2015. Pubmed reference: 26073432. DOI: 10.1016/j.bbadis.2015.06.013.
Perentos, N., Martins, A.Q., Watson, T.C., Bartsch, U., Mitchell, N.L., Palmer, D.N., Jones, M.W., Morton, A.J. :
Translational neurophysiology in sheep: measuring sleep and neurological dysfunction in CLN5 Batten disease affected sheep. Brain 138:862-74, 2015. Pubmed reference: 25724202. DOI: 10.1093/brain/awv026.
2014 Hughes, S.M., Hope, K.M., Xu, J.B., Mitchell, N.L., Palmer, D.N. :
Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy. Neurobiol Dis 62:543-50, 2014. Pubmed reference: 24269732. DOI: 10.1016/j.nbd.2013.11.011.
2013 Bond, M., Holthaus, S.M., Tammen, I., Tear, G., Russell, C. :
Use of model organisms for the study of neuronal ceroid lipofuscinosis. Biochim Biophys Acta 1832:1842-65, 2013. Pubmed reference: 23338040. DOI: 10.1016/j.bbadis.2013.01.009.
2008 Frugier, T., Mitchell, NL., Tammen, I., Houweling, PJ., Arthur, DG., Kay, GW., van Diggelen, OP., Jolly, RD., Palmer, DN. :
A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3. Neurobiol Dis 29:306-15, 2008. Pubmed reference: 17988881. DOI: 10.1016/j.nbd.2007.09.006.
2002 Jolly, R.D., Arthur, D.G., Kay, G.W., Palmer, D.N. :
Neuronal ceroid-lipofuscinosis in Borderdale sheep New Zealand Veterinary Journal 50:199-202, 2002.

Edit History

  • Created by Frank Nicholas on 02 Dec 2009
  • Changed by Frank Nicholas on 08 Oct 2011
  • Changed by Frank Nicholas on 09 Dec 2011
  • Changed by Frank Nicholas on 20 Aug 2013